Activating transcription factor 4

被引:412
|
作者
Ameri, Kurosh
Harris, Adrian L.
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, CCSR S, Stanford, CA 94305 USA
[2] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK, Oxford OX3 9DS, England
关键词
ATF4; hypoxia; anoxia; cancer;
D O I
10.1016/j.biocel.2007.01.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activating transcription factor 4 (ATF4) belongs to the ATF/CREB (activating transcription factor/cyclic AMP response element binding protein) family of basic region-leucine zipper (bZip) transcription factors, which have the consensus binding site cAMP responsive element (CRE). ATF4 has numerous dimerization partners. ATF4 is induced by stress signals including anoxia/hypoxia, endoplasmic reticulum stress, amino acid deprivation, and oxidative stress. ATF4 expression is regulated transcriptionally, translationally via the PERK pathway of eIF2 alpha phosphorylation, and posttranslationally by phosphorylation, which targets ATF4 to proteasomal degradation. ATF4 regulates the expression of genes involved in oxidative stress, amino acid synthesis, differentiation, metastasis and angiogenesis. Transgenic studies have demonstrated ATF4 to be involved in hematopoiesis, lens and skeletal development, fertility, proliferation, differentiation, and long-term memory. ATF4 expression is upregulated in cancer. Since ATF4 is induced by tumour microenvironmental factors, and regulates processes relevant to cancer progression, it might serve as a potential therapeutic target in cancer. (C) 2007 Published by Elsevier Ltd.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 50 条
  • [21] HEPATOCYTE ACTIVATING TRANSCRIPTION FACTOR 3 PROTECTS AGAINST STEATOHEPATITIS VIA HEPATOCYTE NUCLEAR FACTOR 4α
    Xu, Yanyong
    Hu, Shuwei
    Jadhav, Kavita
    Zhu, Yingdong
    Pan, Xiaoli
    Yin, Liya
    Zhang, Yanqiao
    HEPATOLOGY, 2021, 74 : 1067A - 1067A
  • [22] Upregulation of the Coagulation Factor VII Gene during Glucose Deprivation Is Mediated by Activating Transcription Factor 4
    Cronin, Katherine R.
    Mangan, Thomas P.
    Carew, Josephine A.
    PLOS ONE, 2012, 7 (07):
  • [23] Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4α
    Xu, Yanyong
    Hu, Shuwei
    Jadhav, Kavita
    Zhu, Yingdong
    Pan, Xiaoli
    Bawa, Fathima Cassim
    Yin, Liya
    Zhang, Yanqiao
    DIABETES, 2021, 70 (11) : 2506 - 2517
  • [24] Activating transcription factor 3 is upregulated in hypospadias
    Liu, BC
    Wang, Z
    Liu, GT
    Agras, K
    Ebbers, M
    Willingham, E
    Baskin, LS
    JOURNAL OF UROLOGY, 2005, 173 (04): : 193 - 193
  • [25] Activating transcription factor 6 in the endothelial context
    Barabutis, Nektarios
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 80
  • [26] Activating transcription factor 2 in mesenchymal tumors
    Endo, Makoto
    Su, Le
    Nielsen, Torsten O.
    HUMAN PATHOLOGY, 2014, 45 (02) : 276 - 284
  • [27] Activating transcription factor 3 and the nervous system
    Hunt, David
    Raivich, Gennadij
    Anderson, Patrick Norval
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2012, 5
  • [28] Mechanistic Target of Rapamycin and Activating Transcription Factor 4 Regulate TGF-β-induced Transcription in Lung Fibroblasts
    Hamanaka, R. B.
    Shin, K.
    Cetin-Atalay, R.
    Meliton, A. Y.
    Szafran, J.
    Woods, P. S.
    Sun, K.
    Shamaa, R.
    Mutlu, G. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [29] Role of activating transcription factor 4 in the hepatic response to amino acid depletion by asparaginase
    Rana J. T. Al-Baghdadi
    Inna A. Nikonorova
    Emily T. Mirek
    Yongping Wang
    Jinhee Park
    William J. Belden
    Ronald C. Wek
    Tracy G. Anthony
    Scientific Reports, 7
  • [30] Activating transcription factor 4 in erythroid development and β-thalassemia: a powerful regulator with therapeutic potential
    Li, Jingmin
    Lv, Aixiang
    Chen, Meihuan
    Xu, Liangpu
    Huang, Hailong
    ANNALS OF HEMATOLOGY, 2024, 103 (08) : 2659 - 2670